Back to Search
Start Over
Seven cancer patients receiving guselkumab for treatment of moderate-to-severe psoriasis.
- Source :
-
Dermatology reports [Dermatol Reports] 2022 Mar 17; Vol. 14 (3), pp. 9282. Date of Electronic Publication: 2022 Mar 17 (Print Publication: 2022). - Publication Year :
- 2022
-
Abstract
- Competing Interests: Conflict of interest: The authors declare no potential conflict of interest.
Details
- Language :
- English
- ISSN :
- 2036-7392
- Volume :
- 14
- Issue :
- 3
- Database :
- MEDLINE
- Journal :
- Dermatology reports
- Publication Type :
- Academic Journal
- Accession number :
- 36199899
- Full Text :
- https://doi.org/10.4081/dr.2022.9282